+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
From
From
Biobetters - Global Strategic Business Report - Product Thumbnail Image

Biobetters - Global Strategic Business Report

  • Report
  • August 2025
  • 488 Pages
  • Global
From
Inhalable Drugs - Global Strategic Business Report - Product Thumbnail Image

Inhalable Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 270 Pages
  • Global
From
From
From
Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Leukemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Leukemia Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 193 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 950 Pages
  • Global
From
From
Loading Indicator